Page last updated: 2024-08-16

triamterene and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

triamterene has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Califano, A; Hirschhorn, T; Shimada, K; Small, JC; Stockwell, BR; Stokes, ME; Vasciaveo, A	1

Other Studies

1 other study(ies) available for triamterene and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid

Article	Year
Mesenchymal subtype neuroblastomas are addicted to TGF-βR2/HMGCR-driven protein geranylgeranylation. Scientific reports, 2020, 07-01, Volume: 10, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lovastatin; Methotrexate; N-Myc Proto-Oncogene Protein; Neuroblastoma; Protein Prenylation; Receptor, Transforming Growth Factor-beta Type II; RNA, Small Interfering; Signal Transduction; Triamterene	2020

Article

Year

Mesenchymal subtype neuroblastomas are addicted to TGF-βR2/HMGCR-driven protein geranylgeranylation.

Scientific reports, 2020, 07-01, Volume: 10, Issue:1

Topics: Antineoplastic Agents; Apoptosis; Biomarkers, Tumor; Cell Line, Tumor; Fluvastatin; Humans; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Lovastatin; Methotrexate; N-Myc Proto-Oncogene Protein; Neuroblastoma; Protein Prenylation; Receptor, Transforming Growth Factor-beta Type II; RNA, Small Interfering; Signal Transduction; Triamterene

2020